R&D Trends

C3 Jian and Chinese University establish clinical research center

Monday, May 2, 2011 12:17 PM

California-based C3 Jian has signed an agreement with the West China School of Stomatology at Sichuan University (“West China”) to create a joint clinical research center to test new oral healthcare products in human clinical trials. It will be located at West China’s facilities in Chengdu, China. The research center will operate under U.S. FDA’s GCP.

More... »

Taiwan’s ScinoPharm expands

Wednesday, April 27, 2011 11:52 AM

Tainan, Taiwan-based ScinoPharm develops and manufactures active pharmaceutical ingredients (APIs). The company offers a full range of API services from process development, production of early phase clinical trial material to large-scale manufacturing for commercial launches.

More... »

Developers partner to deliver non-additive ADHD drug

Wednesday, April 27, 2011 11:25 AM

New Jersey-based MonoSol Rx, the developer of PharmFilm drug delivery technology, has entered into a development and commercialization partnership with Iowa-based KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of attention deficit hyperactivity disorder (ADHD), pain, and cardiovascular disease, according to FierceDrugDelivery.

More... »

AstraZeneca will demolish research labs in Delaware

Monday, April 25, 2011 01:30 PM

AstraZeneca will tear down three research laboratory buildings at its headquarters in Fairfax, Delaware, as part of its global restructuring, according to delaware online.

More... »

Study: Pharma should invest in public health campaigns

Tuesday, April 19, 2011 11:11 AM

Pharmaceutical companies should consider investing in public health campaigns as a way to help with the challenges facing healthcare systems, according to a report discussed in Pharma Times.

More... »

Warner to cut 500 jobs

Monday, April 18, 2011 01:28 PM

After losing patent protection on their osteoporosis drug Actonel, Ireland-based Warner Chilcott is restructuring its E.U. operations and plans to cut 500 jobs in the process, according to Fierce Pharma. Actonel brought in about 70% of Warner's sales in Western Europe in 2010, and the drug is up against generic competition.

More... »

Report: Some sponsors more prepared to lead the way in personalized medicine than others

Monday, April 18, 2011 08:05 AM

As the pharmaceutical industry’s investment in personalized medicine leads to development of an increasing number of targeted therapies, particularly for cancer patients, some drug sponsors have shown greater commitment and more structure in their approach than others, according to a new report by consulting firm Diaceutics.

More... »

Indian pharmaceutical industry to reach $20 billion

Thursday, April 14, 2011 11:45 AM

The Indian pharmaceutical industry is expected to reach $20 billion by 2015, which would make it one of the world's top 10 pharmaceuticals markets, according to the Associated Chambers of Commerce and Industry in India.

More... »

Merck to cut jobs

Wednesday, April 13, 2011 01:16 PM

Merck is cutting production and staff at their Riverside, Pa. manufacturing plant.  The company plans to outsource some work and sell the plant's fermentation operations, according to Fierce Pharma.

More... »

Pieris and Daiichi Sankyo partner to develop Anticalin therapeutics

Tuesday, April 12, 2011 12:22 PM

Germany-based Pieris will collaborate with Japan-based Daiichi Sankyo and sign a licensed agreement under which Pieris will apply its Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets. As part of the agreement, Pieris will be responsible for early preclinical development for Anticalin drug candidates, and Daiichi Sankyo will assume responsibility for further development and marketing of the Anticalin compounds.

More... »